EW Healthcare Partners, L.P. 13D and 13G filings for EyePoint Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-08 5:28 pm Sale |
2023-12-04 | 13D | EyePoint Pharmaceuticals, Inc. EYPT |
EW Healthcare Partners, L.P. | 2,337,786 5.000% |
-1,312,606 (-35.96%) |
Filing |
| 2023-08-30 5:22 pm Sale |
2019-03-28 | 13D | EyePoint Pharmaceuticals, Inc. EYPT |
EW Healthcare Partners, L.P. | 3,650,392 10.400% |
-540,004 (-12.89%) |
Filing |